Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study

To see complete record on, please visit this link

Id: NCT04718792

Organisation Name: Psychiatric Centre Rigshospitalet

Overal Status: Not yet recruiting

Start Date: July 1, 2022

Last Update: June 2, 2022

Lead Sponsor: Anders Fink-Jensen, MD, DMSci

Brief Summary: The purpose of this project is to assess the feasibility and safety of administering a single dose of psilocybin to patients diagnosed with alcohol use disorder (AUD). In addition the investigators will establish the pharmacokinetic properties of the active metabolite psilocin. This is the first step in a research project that has the overall aim to evaluate the efficacy of a single administration of psilocybin as an intervention for treatment of AUD.

  • Alcohol Use Disorder (AUD)

Total execution time in seconds: 0.19483304023743